Ceribell (CBLL) Change in Account Payables (2023 - 2026)
Ceribell (CBLL) posted Change in Account Payables of -$857000.0 for Q1 2026, down 245.5% on a QoQ basis from $589000.0 in Q4 2025, and down 348.41% year-over-year from $345000.0 in Q1 2025.
Ceribell (CBLL) Change in Account Payables (2023 - 2026) Analysis & Trends
Ceribell's Change in Account Payables history runs 4 years deep, the most recent figure standing at -$857000.0 for Q1 2026.
- Quarterly Change in Account Payables fell 348.41% year-over-year to -$857000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $543000.0 (up 86.6% YoY) and the FY2025 annual result came in at $1.7 million, up 598.0% from the prior year.
- Change in Account Payables was -$857000.0 for Q1 2026 at Ceribell, down from $589000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.0 million in Q2 2025 and bottomed at -$903000.0 in Q4 2024.
- A 4-year average of $59900.0 and a median of $151000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2025 — Change in Account Payables soared 50900.0% — and 2026, when it tumbled 348.41%.
- Ceribell's Change in Account Payables stood at -$539000.0 in 2023, then tumbled by 67.53% to -$903000.0 in 2024, then soared by 165.23% to $589000.0 in 2025, then slumped by 245.5% to -$857000.0 in 2026.
- Business Quant data shows CBLL's Change in Account Payables at -$857000.0 in Q1 2026, $589000.0 in Q4 2025, and -$205000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | -857,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -857,000.00 |
| Mar 31, 2026 | -857,000.00 |
| Dec 31, 2025 | 589,000.00 |
| Dec 31, 2025 | 589,000.00 |
| Sep 30, 2025 | -205,000.00 |
| Sep 30, 2025 | -205,000.00 |
| Jun 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 345,000.00 |
| Mar 31, 2025 | 345,000.00 |
| Dec 31, 2024 | -903,000.00 |
| Dec 31, 2024 | -903,000.00 |
| Sep 30, 2024 | 851,000.00 |
| Sep 30, 2024 | 851,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | 304,000.00 |
| Mar 31, 2024 | 304,000.00 |
| Dec 31, 2023 | -539,000.00 |
| Dec 31, 2023 | -539,000.00 |